Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer.
about
Unravelling signal escape through maintained EGFR activation in advanced non-small cell lung cancer (NSCLC): new treatment optionsContinued EGFR Inhibition With Postprogression Chemotherapy: Where Do We Stand?Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients.Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung CancerActivity of erlotinib when dosed below the maximum tolerated dose for EGFR-mutant lung cancer: Implications for targeted therapy development.Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study.Feasibility of continuing crizotinib therapy after RECIST-PD in advanced non-small cell lung cancer patients with ALK/ROS-1 mutations.Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma.
P2860
Q28075291-CC6FE54D-C224-4575-9FD7-826E277E5647Q36478759-B0F909DE-CEE1-4FBC-B762-98428819515CQ37164590-F6322F42-A10B-49E0-A278-41CAD7188920Q38640618-29E695F3-4C5D-41E0-9B13-B4ADB860CC52Q38880324-59779404-6CA2-4509-8891-B8C1547673EBQ38927992-3569A4A7-9F08-4604-831F-22C06163E331Q47548020-87836216-2C74-4A77-893F-DE0001FBC99CQ54143053-C23E74DD-800F-4E52-AB72-AB65DCC60A7BQ54977963-8AE5B6AF-C19F-447A-8864-9B18FCFA1348Q54990179-A13439EC-D855-4875-B861-7343DF04AD34
P2860
Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Delay of treatment change afte ...... r receptor-mutant lung cancer.
@ast
Delay of treatment change afte ...... r receptor-mutant lung cancer.
@en
type
label
Delay of treatment change afte ...... r receptor-mutant lung cancer.
@ast
Delay of treatment change afte ...... r receptor-mutant lung cancer.
@en
prefLabel
Delay of treatment change afte ...... r receptor-mutant lung cancer.
@ast
Delay of treatment change afte ...... r receptor-mutant lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Delay of treatment change afte ...... r receptor-mutant lung cancer.
@en
P2093
Bruce E Johnson
David M Jackman
Geoffrey R Oxnard
Lecia V Sequist
Mizuki Nishino
Peter C Lo
Suzanne E Dahlberg
P2860
P304
P356
10.1002/CNCR.29397
P407
P50
P577
2015-04-15T00:00:00Z